Mayne Pharma Group Ltd has released a press release.
FDA approval of novel oral contraceptive NEXTSTELLIS
Filed with ASX ·
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
Earlier from Mayne Pharma
- 2021 Half Year Investor Presentation
- 2021 Half Year Media Release
- Chairman and CEOs Addresses to Shareholders
- Mayne Pharma provides update on Womens Health pipeline
- 2020 Full Year Investor Presentation
Later from Mayne Pharma
- Class action proceeding
- 2021 Full Year Investor Presentation
- 2021 Full Year Media Release
- 2021 Mayne Pharma AGM Speeches
- Mayne Pharma expands US dermatology portfolio
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma